Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Julia W Gargano"'
Autor:
Megan Wallace, Jennifer P Collins, Heidi Moline, Ian D Plumb, Monica Godfrey, Rebecca L Morgan, Doug Campos-Outcalt, Sara E Oliver, Kathleen Dooling, Julia W Gargano
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278624 (2022)
In December 2020, an interim recommendation for the use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years was made under Food and Drug Administration's Emergency Use Authorization. In preparation for Biologics License Application approv
Externí odkaz:
https://doaj.org/article/2e62f4eb367f440080dbfa2ca66fcfd5
Autor:
Susan Hariri, Martin Steinau, Allen Rinas, Julia W Gargano, Christina Ludema, Elizabeth R Unger, Alicia L Carter, Kathy L Grant, Melanie Bamberg, James E McDermott, Lauri E Markowitz, Noel T Brewer, Jennifer S Smith
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34044 (2012)
HPV typing using formalin fixed paraffin embedded (FFPE) cervical tissue is used to evaluate HPV vaccine impact, but DNA yield and quality in FFPE specimens can negatively affect test results. This study aimed to evaluate 2 commercial assays for HPV
Externí odkaz:
https://doaj.org/article/8d547a43316c43ed85078ae33ffc02ac
Autor:
Jaimie Z. Shing, Pamela C. Hull, Yuwei Zhu, Julia W. Gargano, Lauri E. Markowitz, Angela A. Cleveland, Manideepthi Pemmaraju, Ina U. Park, Erin Whitney, Edward F. Mitchel, Marie R. Griffin
Publikováno v:
Papillomavirus Research, Vol 7, Iss , Pp 141-149 (2019)
Introduction: Evidence of human papillomavirus (HPV) vaccine impact on anogenital warts (AGWs) by race or urbanicity in the US is lacking. We evaluated HPV vaccine impact in Tennessee by assessing AGW trends among Tennessee Medicaid (TennCare) enroll
Externí odkaz:
https://doaj.org/article/a1f876a6554142eb80d69b7f9e700c6b
Autor:
Julia W, Gargano, Nancy, McClung, Rayleen M, Lewis, Ina U, Park, Erin, Whitney, Jessica L, Castilho, Manideepthi, Pemmaraju, Linda M, Niccolai, Monica, Brackney, Emilio, DeBess, Sara, Ehlers, Nancy M, Bennett, Mary, Scahill, Angela A, Cleveland, Troy D, Querec, Elizabeth R, Unger, Lauri E, Markowitz
Publikováno v:
International Journal of Cancer. 152:137-150
Declines in cervical intraepithelial neoplasia grades 2 to 3 and adenocarcinoma in situ (CIN2+) observed among young women suggest impact from human papillomavirus (HPV) vaccination. To further evaluate vaccine impact including cross-protection and t
Autor:
Elizabeth R. Unger, George Birdsong, Talaat S. Tadros, Lisa C. Flowers, Ira R. Horowitz, Martin Steinau, Mack T. Ruffin IV, Daisy R. Lee, Rosane Nisenbaum, Julia W. Gargano
PDf file - 59K, Unadjusted risk ratios for CIN3+ vs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0b3a57a74625f2bb4cabf91cd7a4f9
https://doi.org/10.1158/1055-9965.22438281.v1
https://doi.org/10.1158/1055-9965.22438281.v1
Autor:
Elizabeth R. Unger, George Birdsong, Talaat S. Tadros, Lisa C. Flowers, Ira R. Horowitz, Martin Steinau, Mack T. Ruffin IV, Daisy R. Lee, Rosane Nisenbaum, Julia W. Gargano
PDf file - 38K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7428bf5315c857d0ab854db8071e033a
https://doi.org/10.1158/1055-9965.22438284
https://doi.org/10.1158/1055-9965.22438284
Autor:
Elizabeth R. Unger, George Birdsong, Talaat S. Tadros, Lisa C. Flowers, Ira R. Horowitz, Martin Steinau, Mack T. Ruffin IV, Daisy R. Lee, Rosane Nisenbaum, Julia W. Gargano
Background: Recommendations for high-risk human papillomavirus (HR-HPV) testing as an adjunct to cytology for cervical cancer screening differ by age group, because HR-HPV tests lack adequate specificity in women aged Methods: Women ages 18 to 69 (n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e7f19be93c62847859aa3ad6bf0f30
https://doi.org/10.1158/1055-9965.c.6516291.v1
https://doi.org/10.1158/1055-9965.c.6516291.v1
Autor:
Elizabeth R. Unger, George Birdsong, Talaat S. Tadros, Lisa C. Flowers, Ira R. Horowitz, Martin Steinau, Mack T. Ruffin IV, Daisy R. Lee, Rosane Nisenbaum, Julia W. Gargano
PDf file - 53K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c2861dfa66de61c240b091d4b2e44b
https://doi.org/10.1158/1055-9965.22438287
https://doi.org/10.1158/1055-9965.22438287
Autor:
Jacqueline Mix, Mona Saraiya, Benjamin D Hallowell, Brian Befano, Li C Cheung, Elizabeth R Unger, Julia W Gargano, Lauri E Markowitz, Philip E Castle, Tina Raine-Bennett, Joan Walker, Rosemary Zuna, Mark Schiffman, Nicolas Wentzensen, Julia C Gage
Publikováno v:
JNCI: Journal of the National Cancer Institute. 114:845-853
Background Racial and ethnic variations in attribution of cervical precancer and cancer to human papillomavirus (HPV) types may result in different HPV vaccine protection, screening test coverage, and clinical management. Methods Pooling data from 7
Autor:
Lauri E. Markowitz, Gayle E Langley, Heather M. Scobie, Melinda Wharton, Megan J. Wallace, Julia W. Gargano, Tom T. Shimabukuro, Karen R. Broder, Stephen C. Hadler, H. Keipp Talbot, Matthew F. Daley, Julianne Gee, Sara E. Oliver, Eric Weintraub, John R. Su, Danielle Moulia, Matthew E. Oster, Veronica V. McNally, Jose R. Romero, Grace M. Lee
Publikováno v:
Morbidity and Mortality Weekly Report
In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273) vaccine,† and the Advisory Committee on Immunization Practi